Form Bio

Ben Lamm

Colossal Spinout Astromech Acquires Sister Company Form Bio for $230M

by | Nov 17, 2026
The all-stock deal brings together two Dallas companies, pairing Astromech’s evolutionary AI models with Form Bio’s tools for designing genetic medicines. Form Bio co-founder Andrew Busey becomes Astromech’s chief AI officer.
MORE►
Colossal Targets Extinct Antelope—and Adds a New Branch to its De-Extinction ‘Tree of Life’
by | Apr 30, 2026
At a $10 billion valuation—and spinning out new ventures—Colossal names the bluebuck its sixth de-extinction target, extending its biotech platform into antelope conservation through a global BioVault effort.
MORE►
Who Made This Year’s AI 75 List? Meet the North Texans Leading the Pack in Artificial Intelligence
by | Apr 30, 2025
Dallas Innovates, in partnership with the Dallas Regional Chamber, once again is recognizing the most innovative leaders in AI in Dallas-Fort Worth. From visionaries and mavericks to transformers and academics, AI 75's class of 2025 are the AI pacesetters you need to know now.
MORE►
Venture Dallas Announces 2024 Startup of the Year Awards Finalists, Expands Field to 20 After Record Nominations
by | Oct 21, 2024
Winners will be revealed in a live announcement at the George W. Bush Presidential Center during the Venture Dallas Summit on October 30.
MORE►

Edge of Extinction: Pioneering Texas Biotech Colossal and BioRescue Race to Save the Northern White Rhino Species

With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE►
BioNTX iC3 Summit to Fuel North Texas Life Science Ecosystem, Honor 8 Rising Stars
by | Sep 14, 2023
The North Texas bioscience organization, a driving force for growth in the regional ecosystem, will convene leaders at its flagship conference to catalyze industry opportunities, spotlight emerging companies, and make connections.

See who made this year's Rising Stars list—and how you can attend the summit.
MORE►
Google Cloud Launches AI-Powered Multiomics Suite, Taps Dallas-Based Colossal and Form Bio To Help Accelerate Life Science Research
by | May 19, 2023
Google Cloud has unveiled its AI-powered Multiomics Suite, which aims to accelerate the discovery and interpretation of genomic data, helping companies design precision treatments. As part of the rollout, Google Cloud noted that Dallas-based Colossal Biosciences has adopted the Multiomics Suite, and that Colossal spinout Form Bio has been selected to help other organizations adopt it. See what the new suite can do—and how it could help life get scienced.
MORE►

Follow the Money: Book.io Aims to Put E-Books on the Blockchain with New Funding, Tech Startup Kalpa Aims to Raise $1M, and More

by | Sep 30, 2022
In this week’s North Texas deal flow, you’ll also find news about crowdfunding platform Harvest Return landing $2.5M; Supply’s acquisition by Foundry Brands; Moss Adams acquiring local CPA firm Kurtz & Company P.C.; Tri Global Energy being acquired for $270M by Canada's Enbridge; and more.
MORE►
Form Bio Spins Out of Colossal Bioscience to Offer Scientists the ‘Missing Piece’
by | Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.

The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE►